Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Business Wire
Not intended for UK MediaCollaboration spans across various indications with an initial focus on cardiovascular and kidney diseases, addressing areas of significant unmet medical needBayer to leverage VUMC’s data resources to enable data-driven insights and accelerate drug discovery and developmentCollaboration will strengthen Bayer’s pharmaceutical development portfolio harnessing cutting-edge science and real-world data BERLIN & NASHVILLE, Tenn.--(BUSINESS WIRE)--Bayer and Vanderbilt University Medical Center (VUMC) today announced that they have entered a strategic five-year collaboration agreement to advance innovative therapies from target identification through Investigational New Drug (IND) application. The agreement spans across all indications currently pursued by Bayer, initially focusing on cardiovascular and kidney diseases, two therapeutic areas with significant unmet medical need.The collaboration will leverage VUMC’s resource platform, including its comprehensive da
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Bayer: Timing Upside In 2025, More Upside Possible But Risky In 2026E (Downgrade) [Seeking Alpha]Seeking Alpha
- Bayer Shares Surge After Supreme Court To Hear Roundup Appeal; Is The Decade-Long Bear Market Over? [zero hedge]zero hedge
- US Supreme Court Agrees To Hear Monsanto Weedkiller Case [Barron's]Barrons
- Supreme Court may block thousands of lawsuits over Monsanto's weed killer [Los Angeles Times (CA)]Los Angeles Times
- Supreme Court agrees to hear longstanding fight over Roundup cancer claims [CNN]CNN